Skip to main content
OpenTrials

Clinical trial condition

Small Cell Lung Cancer

Explore clinical trials studying Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

242 public trials 55 recruiting studies
Refine in advanced search Browse all conditions

Small Cell Lung Cancer trial results

Recruiting

Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)

NCT07531095

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • New York University Cancer Institute New York, United States
  • Baptist Cancer Center Memphis, Tennessee, United States
  • Next Virginia Fairfax, Virginia, United States
  • Adana Sehir Egitim ve Arastirma Hastanesi Adana, Turkey (Türkiye)
View Trial Details
Recruiting

Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment

NCT05363280

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +25 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Cleveland Clinic Florida Weston, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • Siteman Cancer Center, Washington University St Louis, Missouri, United States
View Trial Details
Recruiting

MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer

NCT05903092

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Stage Small Cell Lung Cancer, +11 more
Locations
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Karmanos Cancer Center (Wayne State University) Detroit, Michigan, United States
  • University of Virginia Health System Charlottesville, Virginia, United States
View Trial Details
Recruiting

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

NCT06586957

Conditions
Adnexal Diseases, Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, +62 more
Locations
  • University of Arkansas Medical School Little Rock, Arkansas, United States
  • University of California - Los Angeles Los Angeles, California, United States
  • UCSF San Francisco, California, United States
  • SCRI at HealthOne Denver, Colorado, United States
View all 19 locations
View Trial Details
Recruiting

Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

NCT07424547

Conditions
Adnexal Diseases, Advanced Metastatic Cancer, Breast Cancer, +36 more
Locations
  • BRCR Global Plantation, Florida, United States
  • Florida Clinical Trials Group Plantation, Florida, United States
  • NEXT Oncology Austin Austin, Texas, United States
  • NEXT Oncology San Antonio San Antonio, Texas, United States
View Trial Details
Recruiting

Immunonutrition Reduces Acute Esophagitis After Thoracic Radiotherapy in Lung Cancer

NCT06840704

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
Locations
  • Hunan Cancer Hospital Changsha, Hunan, China
  • Third Xiangya Hospital, Central South University Changsha, Hunan, China
  • Xiangya Hospital of Central South University, Changsha, Hunan, China
  • The First People's Hospital of Chenzhou Chenzhou, Hunan, China
View Trial Details
Recruiting

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

NCT05983432

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +62 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • City of Hope Cancer Center Duarte, California, United States
  • Chao Family Comprehensive Cancer Care and Ambulatory Care Irvine, California, United States
  • Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
View all 39 locations
View Trial Details

Related conditions